Accuracy of Maxillary Repositioning During Orthognathic Surgery
Launched by CENTRE HOSPITALIER ANNECY GENEVOIS · Nov 24, 2017
Trial Information
Current as of July 05, 2025
Completed
Keywords
ClinConnect Summary
Orthognathic surgery aims to correct jaw position taking into account esthetic and functional criteria (dental occlusion, lip position, breathing...). These surgeries are planned only after the end of the growing period and in association with orthodontics. It is necessary to wait the end of facial growth to expect a stable result especially concerning mandibular. The age limit seems to be around 15 to 16 years old for retromandibular deformities and around 18 years old for premandibular deformities.
These surgeries are planned using clinical, radiological and dental cast data. Occlusal sp...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients needing orthognathic surgery with mobilization of the maxilla via a Le Fort I osteotomy, alone or associated to a mandibular osteotomy, whatever the indication (poor occlusion, sleep apnea, temporo-mandibular dysfunction...)
- • patient over 16 years old
- • having not expressed any opposition to the collection of his/her personal data for this study (patient him/herself or holder of parental authority in case of patients younger than 18)
- Exclusion Criteria:
- • pregnancy
- • patients deprived of liberty
- • protected adult
- • patients needing maxillary disjunction
About Centre Hospitalier Annecy Genevois
The Centre Hospitalier Annecy Genevois (CHAG) is a leading healthcare institution located in the Auvergne-Rhône-Alpes region of France, renowned for its commitment to advancing medical research and enhancing patient care. As a clinical trial sponsor, CHAG leverages its multidisciplinary expertise and state-of-the-art facilities to conduct innovative research across various therapeutic areas. The center prioritizes collaboration with academic institutions and industry partners to facilitate the development of new treatments and improve clinical outcomes. With a focus on ethical practices and patient safety, CHAG is dedicated to contributing valuable insights to the global medical community through its rigorous clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Georges Bettega, MD/PhD
Principal Investigator
CH Annecy Genevois
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials